Centene Corporation’s CNC margin recovery story appears to be shifting from strategy to execution. The company has rolled out several initiatives to better manage medical costs, modernize and standardize processes, and strengthen payment integrity. With those efforts already contributing to stronger-than-expected first-quarter results, the focus now is on whether the momentum can sustain margin expansion.
Rather than relying solely on higher reimbursement rates, the insurer is tackling rising healthcare costs by standardizing utilization management, expanding clinical programs and optimizing provider networks through data analytics. It is also stepping up efforts to curb fraud, waste and abuse, while AI-enabled tools improve forecasting, detect abnormal claims earlier and strengthen cost discipline. Together, these measures should support more disciplined medical cost management and steadier profitability.
The operational gains are becoming visible. Medicaid's health benefits ratio improved 50 basis points year over year to 93.1%, marking the third consecutive quarter of progress. Stabilizing behavioral health trends and better oversight of applied behavior analysis (ABA) services further suggest the improvement is becoming increasingly structural. Reflecting the strong start, Centene raised its 2026 adjusted EPS guidance to more than $3.40.
Medical cost trends and reimbursement updates will remain key to sustaining Centene's margin recovery. Meanwhile, constructive Medicaid rate discussions should further enhance profitability by better aligning reimbursement with healthcare costs. Coupled with disciplined operational execution, these efforts position the insurer to continue improving margins and deliver more consistent earnings over time.
How Are Competitors Faring?
Some of CNC's major competitors in the managed care space are Elevance Health, Inc. ELV and Molina Healthcare, Inc. MOH.
Elevance Health is focused on improving margins through operational discipline rather than relying solely on pricing. ELV continues to strengthen care management, expand value-based care arrangements and use advanced analytics to better manage medical costs across its Medicaid and Medicare businesses.
Molina Healthcare continues to focus on disciplined medical cost management and payment integrity to protect margins. Investments in care coordination, utilization management and technology have helped MOH manage healthcare costs while supporting consistent margin growth.
Centene’s Price Performance, Valuation & Estimates
Shares of CNC have rallied 63.1% in the year-to-date period compared with the industry’s growth of 28.7%.
Image Source: Zacks Investment Research
From a valuation standpoint, Centene trades at a forward price-to-earnings ratio of 16.97, below the industry average of 18.55. CNC carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $3.46 per share, implying 66.4% growth from the year-ago period’s level.
Image Source: Zacks Investment Research
CNC stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Radical New Technology Could Hand Investors Huge Gains
Quantum Computing is the next technological revolution, and it could be even more advanced than AI.
While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.
Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power .
Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.
See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Centene Corporation (CNC): Free Stock Analysis Report
Molina Healthcare, Inc (MOH): Free Stock Analysis Report
Elevance Health, Inc. (ELV): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).